MGI Tech Co., Ltd.

MGI Tech Co. faced a challenging day on June 8, 2026, with a significant decline in stock value. Over the past week and month, the company has underperformed compared to the broader market. Year-to-date, MGI Tech's performance is down, reflecting ongoing pressures and limited growth prospects.

MGI Tech Co. experienced notable trading activity, reaching an intraday high of CNY 54.18. However, the company has struggled over the past year, with a significant decline in net sales and operating profit. Its market capitalization is CNY 21,719 million, reflecting its large-cap status.

MGI Tech Co. faced a significant stock decline, dropping 3.31% on June 1, 2026, amid ongoing market challenges. Over the past year, the stock has decreased by 30.76%, despite a 49.3% increase in profits. The company holds a market capitalization of CNY 21,719 million.

MGI Tech Co. has seen a rise in stock performance today, reaching an intraday high. However, the company faces longer-term challenges, with a significant decline in stock value over the past year and a contraction in net sales and operating profit. Its financial indicators suggest a need for strategic reassessment.

MGI Tech Co. has faced substantial stock declines, with a 4.98% drop on March 23, 2026, and a 10.84% decrease over the past week. Year-to-date, the stock is down 19.35%, and long-term trends show a 40.09% decline over the past year, indicating ongoing challenges for the company.

MGI Tech Co. faced a notable decline in its stock price, reflecting ongoing market challenges. The company has experienced significant decreases over various time frames, including a year-to-date drop of 15.13% and a substantial annual decline of 43.43%. Financial metrics indicate struggles with long-term growth and profitability.

MGI Tech Co. faced a notable decline in its stock price, reflecting ongoing market challenges. The company has experienced significant drops in stock performance over various timeframes, alongside declining net sales and operating profit. Its financial metrics indicate difficulties, with a negative return on equity and no dividend offerings.

MGI Tech Co., a key player in the Pharmaceuticals & Biotechnology sector, faced a notable stock decline today, reflecting ongoing market challenges. Over the past month, the company has experienced significant decreases in stock performance and long-term growth metrics, raising concerns about its competitive position in the industry.